BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 20421972)

  • 1. Comparison of the immune responses induced by chimeric alphavirus-vectored and formalin-inactivated alum-precipitated measles vaccines in mice.
    Bergen MJ; Pan CH; Greer CE; Legg HS; Polo JM; Griffin DE
    PLoS One; 2010 Apr; 5(4):e10297. PubMed ID: 20421972
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A chimeric alphavirus replicon particle vaccine expressing the hemagglutinin and fusion proteins protects juvenile and infant rhesus macaques from measles.
    Pan CH; Greer CE; Hauer D; Legg HS; Lee EY; Bergen MJ; Lau B; Adams RJ; Polo JM; Griffin DE
    J Virol; 2010 Apr; 84(8):3798-807. PubMed ID: 20130066
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modulation of disease, T cell responses, and measles virus clearance in monkeys vaccinated with H-encoding alphavirus replicon particles.
    Pan CH; Valsamakis A; Colella T; Nair N; Adams RJ; Polack FP; Greer CE; Perri S; Polo JM; Griffin DE
    Proc Natl Acad Sci U S A; 2005 Aug; 102(33):11581-8. PubMed ID: 16037211
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neonatal immunization with a Sindbis virus-DNA measles vaccine induces adult-like neutralizing antibodies and cell-mediated immunity in the presence of maternal antibodies.
    Capozzo AV; Ramírez K; Polo JM; Ulmer J; Barry EM; Levine MM; Pasetti MF
    J Immunol; 2006 May; 176(9):5671-81. PubMed ID: 16622037
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of immune responses induced by intramuscular vaccination with DNA vaccines encoding measles virus hemagglutinin and/or fusion proteins.
    Song MK; Vindurampulle CJ; Capozzo AV; Ulmer J; Polo JM; Pasetti MF; Barry EM; Levine MM
    J Virol; 2005 Aug; 79(15):9854-61. PubMed ID: 16014946
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Attenuated Salmonella enterica serovar Typhi and Shigella flexneri 2a strains mucosally deliver DNA vaccines encoding measles virus hemagglutinin, inducing specific immune responses and protection in cotton rats.
    Pasetti MF; Barry EM; Losonsky G; Singh M; Medina-Moreno SM; Polo JM; Ulmer J; Robinson H; Sztein MB; Levine MM
    J Virol; 2003 May; 77(9):5209-17. PubMed ID: 12692223
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A role for nonprotective complement-fixing antibodies with low avidity for measles virus in atypical measles.
    Polack FP; Hoffman SJ; Crujeiras G; Griffin DE
    Nat Med; 2003 Sep; 9(9):1209-13. PubMed ID: 12925847
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dose-dependent protection against or exacerbation of disease by a polylactide glycolide microparticle-adsorbed, alphavirus-based measles virus DNA vaccine in rhesus macaques.
    Pan CH; Nair N; Adams RJ; Zink MC; Lee EY; Polack FP; Singh M; O'Hagan DT; Griffin DE
    Clin Vaccine Immunol; 2008 Apr; 15(4):697-706. PubMed ID: 18287579
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Measles Virus-Based Vaccine Candidate Mediates Protection against Zika Virus in an Allogeneic Mouse Pregnancy Model.
    Nürnberger C; Bodmer BS; Fiedler AH; Gabriel G; Mühlebach MD
    J Virol; 2019 Feb; 93(3):. PubMed ID: 30429338
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protection against challenge with measles virus (MV) in infant macaques by an MV DNA vaccine administered in the presence of neutralizing antibody.
    Premenko-Lanier M; Rota PA; Rhodes GH; Bellini WJ; McChesney MB
    J Infect Dis; 2004 Jun; 189(11):2064-71. PubMed ID: 15143474
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Generation of a More Immunogenic Measles Vaccine by Increasing Its Hemagglutinin Expression.
    Julik E; Reyes-Del Valle J
    J Virol; 2016 Jun; 90(11):5270-5279. PubMed ID: 26984727
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vaxfectin adjuvant improves antibody responses of juvenile rhesus macaques to a DNA vaccine encoding the measles virus hemagglutinin and fusion proteins.
    Lin WH; Vilalta A; Adams RJ; Rolland A; Sullivan SM; Griffin DE
    J Virol; 2013 Jun; 87(12):6560-8. PubMed ID: 23552419
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative evaluation of two hemagglutinating encephalomyelitis coronavirus vaccine candidates in mice.
    Chen K; Zhao K; He W; Gao W; Zhao C; Wang L; Pan W; Song D; Wang C; Gao F
    Clin Vaccine Immunol; 2012 Jul; 19(7):1102-9. PubMed ID: 22518008
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunoglobulin g antibody-mediated enhancement of measles virus infection can bypass the protective antiviral immune response.
    Iankov ID; Pandey M; Harvey M; Griesmann GE; Federspiel MJ; Russell SJ
    J Virol; 2006 Sep; 80(17):8530-40. PubMed ID: 16912303
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protective immunity elicited by measles vaccine exerts anti-tumor effects on measles virus hemagglutinin gene-modified cancer cells in a mouse model.
    Qi Y; Xing K; Zhang L; Zhao F; Yao M; Hu A; Wu X
    J Cancer Res Clin Oncol; 2018 Oct; 144(10):1945-1957. PubMed ID: 30090962
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The recombinant globular head domain of the measles virus hemagglutinin protein as a subunit vaccine against measles.
    Lobanova LM; Eng NF; Satkunarajah M; Mutwiri GK; Rini JM; Zakhartchouk AN
    Vaccine; 2012 Apr; 30(20):3061-7. PubMed ID: 22406109
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Poor immune responses of newborn rhesus macaques to measles virus DNA vaccines expressing the hemagglutinin and fusion glycoproteins.
    Polack FP; Lydy SL; Lee SH; Rota PA; Bellini WJ; Adams RJ; Robinson HL; Griffin DE
    Clin Vaccine Immunol; 2013 Feb; 20(2):205-10. PubMed ID: 23239799
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lentiviral vectors displaying modified measles virus gp overcome pre-existing immunity in in vivo-like transduction of human T and B cells.
    Lévy C; Amirache F; Costa C; Frecha C; Muller CP; Kweder H; Buckland R; Cosset FL; Verhoeyen E
    Mol Ther; 2012 Sep; 20(9):1699-712. PubMed ID: 22617109
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An alphavirus-based adjuvant enhances serum and mucosal antibodies, T cells, and protective immunity to influenza virus in neonatal mice.
    Khalil SM; Tonkin DR; Snead AT; Parks GD; Johnston RE; White LJ
    J Virol; 2014 Aug; 88(16):9182-96. PubMed ID: 24899195
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An alphavirus replicon particle chimera derived from venezuelan equine encephalitis and sindbis viruses is a potent gene-based vaccine delivery vector.
    Perri S; Greer CE; Thudium K; Doe B; Legg H; Liu H; Romero RE; Tang Z; Bin Q; Dubensky TW; Vajdy M; Otten GR; Polo JM
    J Virol; 2003 Oct; 77(19):10394-403. PubMed ID: 12970424
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.